Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The 3 Best Coffee Stocks to Own in 2023

By Josh Enomoto, InvestorPlace Contributor

With employers lawing down the law regarding workplace normalization, these coffee stocks may see their addressable market expand.

7 Semiconductor Stocks to Catapult You into the Millionaires’ Club

By Josh Enomoto, InvestorPlace Contributor

With the chipmaking space poised for significant growth ahead, these are the millionaire maker semiconductor stocks to buy.

7 Doomed Stocks Destined for Disaster

By Josh Enomoto, InvestorPlace Contributor

While it’s an ugly and controversial topic, investors must be aware of the doomed stocks to avoid to spare themselves pain.

Why Is Ault Alliance (AULT) Stock Up 60% Today?

By Josh Enomoto, InvestorPlace Contributor

Although diversified enterprise Ault Alliance posted a positive revenue projection, investors need to be leery of AULT stock.

RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring

By Josh Enomoto, InvestorPlace Contributor

Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock.

Load More